Certain thiol inhibitors of endothelin-converting enzyme
申请人:——
公开号:US20020082218A1
公开(公告)日:2002-06-27
Disclosed as endothelin converting enzyme inhibitors are the compounds of the formula
1
wherein the variables have the meanings as defined hereinbefore.
披露的内皮素转化酶抑制剂是具有以下公式的化合物,其中变量的含义如前文所定义。
ANTAGONISTS OF HUMAN INTEGRIN (ALPHA4)(BETA7)
申请人:Morphic Therapeutic, Inc.
公开号:US20190315692A1
公开(公告)日:2019-10-17
Disclosed are small molecule antagonists of α4β7 integrin, and methods of using them to treat a number of specific diseases or conditions.
揭示了α4β7整合素的小分子拮抗剂,以及使用它们治疗多种特定疾病或病况的方法。
An Unusual Conformation of α-Haloamides Due to Cooperative Binding with Zincated Porphyrins
作者:Marina Tanasova、Qifei Yang、Courtney C. Olmsted、Chrysoula Vasileiou、Xiaoyong Li、Mercy Anyika、Babak Borhan
DOI:10.1002/ejoc.200900089
日期:2009.9
with a zinc porphyrin leads to an unprecedented conformation for the determination of the absolute stereochemistry of α-haloamides (α-halocarboxylic acids derivatized with 1,4-phenylenediamine) through the use of exciton-coupled circular dichroism (ECCD). With the use of chiral lactams, whose rotomeric contributions are minimized, both ECCD and NMR spectroscopy demonstrate that the porphyrin favors binding
[EN] CERTAIN THIOL INHIBITORS OF ENDOTHELIN-CONVERTING ENZYME<br/>[FR] CERTAINS INHIBITEURS THIOL D'UNE ENZYME DE CONVERSION D'ENDOTHELINE
申请人:NOVARTIS AG
公开号:WO1999055726A1
公开(公告)日:1999-11-04
(EN) Disclosed as endothelin converting enzyme inhibitors are the compounds of formula (I), wherein the variables have the meanings as defined hereinbefore.(FR) L'invention concerne les composés de la formule (I) comme inhibiteurs de l'enzyme de conversion d'endothéline, les variables ayant les significations données antérieurement.
揭示的内皮素转化酶抑制剂为公式(I)的化合物,其中变量的含义如前所定义。
Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme
申请人:——
公开号:US20030018057A1
公开(公告)日:2003-01-23
Novel thiol derivatives of formula I
1
or of the formula Ia
2
wherein the variables have the meanings as defined hereinbefore.